In the previously mentioned study of HCC, Cox2 expression in HSCs drives an increase in several downstream Cox2 products within the liver, including PGD2, PGE2, and PGF2A (Loo et al., 2017). This evidence concerns the gene PTGS2 and hepatocellular carcinoma.